Published in Mucosal Immunol on June 23, 2010
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol (2011) 2.46
Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol (2013) 1.53
IL-15: a central regulator of celiac disease immunopathology. Immunol Rev (2014) 1.14
Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria. PLoS One (2013) 1.07
Celiac disease: quantity matters. Semin Immunopathol (2012) 1.03
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
Refractory celiac disease: from bench to bedside. Semin Immunopathol (2012) 0.95
The role of the intestinal context in the generation of tolerance and inflammation. Clin Dev Immunol (2011) 0.88
Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge. PLoS One (2012) 0.87
Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes. Clin Exp Immunol (2012) 0.87
Gluten-sensitive enteropathy coincides with decreased capability of intestinal T cells to secrete IL-17 and IL-22 in a macaque model for celiac disease. Clin Immunol (2013) 0.87
Lessons from rodent models in celiac disease. Mucosal Immunol (2014) 0.85
Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat Rev Rheumatol (2015) 0.83
Gut microbes and adverse food reactions: Focus on gluten related disorders. Gut Microbes (2014) 0.81
Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten. Clin Exp Immunol (2012) 0.81
Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study. BMC Gastroenterol (2012) 0.80
Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases. Pflugers Arch (2016) 0.79
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes. Proc Natl Acad Sci U S A (2017) 0.79
Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease. Mediators Inflamm (2013) 0.79
Transcriptome Analysis of CD4+ T Cells in Coeliac Disease Reveals Imprint of BACH2 and IFNγ Regulation. PLoS One (2015) 0.79
Defective expression of scavenger receptors in celiac disease mucosa. PLoS One (2014) 0.78
TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice. PLoS One (2015) 0.76
Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum. J Biol Chem (2015) 0.76
Interleukin-21-mediated TLR4 activation in celiac disease. Dig Dis Sci (2013) 0.75
Effector and suppressor T cells in celiac disease. World J Gastroenterol (2015) 0.75
Coeliac disease: a unique model for investigating broken tolerance in autoimmunity. Clin Transl Immunology (2016) 0.75
Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol (2015) 0.75
The roles of MHC class II genes and post-translational modification in celiac disease. Immunogenetics (2017) 0.75
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med (1998) 5.25
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology (1998) 2.69
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut (1995) 2.29
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85
Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58
HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens (2004) 1.56
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol (2001) 1.50
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45
Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol (1988) 1.43
Celiac disease and risk of fracture in adults--a review. Osteoporos Int (2014) 1.43
Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut (1995) 1.40
HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol (1999) 1.38
T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37
Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31
A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens (1999) 1.22
Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22
T lymphocytes in human gut epithelium preferentially express the alpha/beta antigen receptor and are often CD45/UCHL1-positive. Scand J Immunol (1989) 1.20
Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J Immunol (2001) 1.19
HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens (2003) 1.18
Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology (1997) 1.17
HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol (1992) 1.17
Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease. Gut (2000) 1.15
Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand J Immunol (1987) 1.15
Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens (1997) 1.11
T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol (1994) 1.07
Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol (1997) 1.06
Role of tissue transglutaminase in celiac disease. J Pediatr Gastroenterol Nutr (2000) 1.02
Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics (1996) 1.02
The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens (2000) 1.00
The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. Int Immunol (1998) 0.97
Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol (1997) 0.96
HLA-DQw3.1 and DQw3.2 associated exon polymorphisms detected by oligonucleotide probes. Tissue Antigens (1988) 0.96
Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol (1994) 0.96
Diagnosis and treatment of celiac disease. Mucosal Immunol (2008) 0.96
Production and secretion of immunoglobulins in the gastrointestinal tract. Ann Allergy (1987) 0.95
Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families. Genes Immun (2008) 0.94
Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens (2004) 0.93
Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule. Int Immunol (1994) 0.91
Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur J Hum Genet (2001) 0.91
Gliadin-specific T cell responses in peripheral blood of healthy individuals involve T cells restricted by the coeliac disease associated DQ2 heterodimer. Scand J Immunol (1995) 0.90
HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens (2002) 0.90
Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. Tissue Antigens (2006) 0.89
Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles. Hum Immunol (1990) 0.88
Interferon-gamma-secreting T cells localize to the epithelium in coeliac disease. Scand J Immunol (2002) 0.88
Four novel coeliac disease regions replicated in an association study of a Swedish-Norwegian family cohort. Genes Immun (2009) 0.88
T lymphocyte recognition of a celiac disease-associated cis- or trans-encoded HLA-DQ alpha/beta-heterodimer. J Immunol (1990) 0.88
Surface expression of transglutaminase 2 by dendritic cells and its potential role for uptake and presentation of gluten peptides to T cells. Scand J Immunol (2007) 0.88
Studies of gliadin-specific T-cells in celiac disease. Methods Mol Med (2000) 0.88
Characterization of an HLA-DQ2-specific monoclonal antibody. Influence of amino acid substitutions in DQ beta 1*0202. Hum Immunol (1995) 0.88
Chemiluminescence response of granulocytes from elite athletes during recovery from one or two intense bouts of exercise. Eur J Appl Physiol (2002) 0.87
Density of CD163+ CD11c+ dendritic cells increases and CD103+ dendritic cells decreases in the coeliac lesion. Scand J Immunol (2011) 0.87
Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. Hum Immunol (1989) 0.87
Immunopathology of gluten-sensitive enteropathy. Springer Semin Immunopathol (1997) 0.86
Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin Immunol Immunopathol (1996) 0.86
Getting to grips with gluten. Gut (2000) 0.86
HLA restriction patterns of gliadin- and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients. Tissue Antigens (1998) 0.86
T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation. J Exp Med (2001) 0.85
HLA genotypes and the increased incidence of coeliac disease in Sweden. Scand J Gastroenterol (1996) 0.84
Rapid selection of cultured cells with increased expression of a membrane marker (secretory component). Int J Cancer (1988) 0.82
Interleukin-15 induces interleukin-17 production by synovial T cell lines from patients with rheumatoid arthritis. Scand J Immunol (2011) 0.82
New tool to predict celiac disease on its way to the clinics. Gastroenterology (1998) 0.82
Plasmacytoid dendritic cells are scarcely represented in the human gut mucosa and are not recruited to the celiac lesion. Mucosal Immunol (2013) 0.81
Positive selection of Tac- (CD25) positive cells following T-cell activation. Use of immunomagnetic separation and implications for T-cell cloning. J Immunogenet (1989) 0.81
Clustering of IgA-producing immunocytes related to HLA-DR-positive ducts in normal and inflamed salivary glands. Scand J Immunol (1992) 0.81
The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2. Scand J Immunol (2008) 0.81
T lymphocyte clones recognizing an HLA-DQw3.2-associated epitope involving residue 57 on the DQ beta chain. Hum Immunol (1988) 0.80
Expression of MHC class II determinants by jejunal epithelium in coeliac disease. J Pediatr Gastroenterol Nutr (1988) 0.80
A peptide-binding assay for the disease-associated HLA-DQ8 molecule. Scand J Immunol (1998) 0.80
Antibodies to wheat germ agglutinin in coeliac disease. Clin Exp Immunol (1986) 0.80
Binding of ras oncogene peptides to purified HLA-DQ(alpha 1*0102,beta 1*0602) and -DR(alpha,beta 1*0101) molecules. Scand J Immunol (1994) 0.79
T-cell recognition of HLA class II molecules induced by gamma-interferon on a colonic adenocarcinoma cell line (HT29). Scand J Immunol (1990) 0.79
HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201. Hum Immunol (1995) 0.79
DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases. Tissue Antigens (1995) 0.78
Interactions of lymphoid cells with the epithelial environment. Monogr Allergy (1988) 0.78
Influence on antibody recognition of amino acid substitutions in the cleft of HLA-DQ2 molecules. Suggestive evidence of peptide-dependent epitopes. Hum Immunol (1995) 0.78
The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease. Clin Exp Immunol (2005) 0.78
Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells. Gastroenterology (1998) 0.78
Mucosal immunology and food antigens. Bibl Nutr Dieta (1991) 0.77
Jejunal epithelium of patients with coeliac disease shows enhanced expression of MHC class II subregion products. Adv Exp Med Biol (1988) 0.77
Coeliac disease candidate genes: no association with functional polymorphisms in matrix metalloproteinase 1 and 3 gene promoters. Scand J Gastroenterol (2002) 0.77
The IL12B gene does not confer susceptibility to coeliac disease. Tissue Antigens (2002) 0.76
Gliadin peptide specific intestinal T cells in coeliac disease. Gut (2003) 0.75
Serum antibodies to wheat germ agglutinin and gluten in patients with dermatitis herpetiformis. Arch Dermatol Res (1986) 0.75
Two-colour immunofluorescence marker study of pleomorphic adenomas. Histochemistry (1990) 0.75
Novel HLA-DR2 and -DR3 haplotypes among Norwegian Caucasians. Tissue Antigens (1991) 0.75
Gastrointestinal intraepithelial lymphocytes and T cell lymphomas. Gut (2003) 0.75